We are a young company (www.making-genetics.eu) installed in Spain and devoted to personalized medicine. Our main knowledge is about the realization and interpretation of genomic studies, with special expertise in epigenetics, bioinformatics and nutrigenomics. We are managing an R&D discovery portfolio of diagnostic panels covering assisted reproductive technology, metabolic syndrome, and pharmacogenetics/pharmacoepigenetics of cancer and inflammatory disorders. For this purpose, we are looking for R&D partners collaborating in the discovery, validation, clinical implementation or marketing of new genetic/epigenetic diagnostic panels. We also offer to third parties the management of genomic-based research for the identification of new biomarkers associated with the diagnosis and prognosis of various diseases and differential response to drugs. For this purpose, we support the preparation and initial design project, determining massive biomarkers (genomic, transcriptomic, epigenomic, proteomic, metabolomics), and finally, the statistical and bioinformatics of the results.
Looking for a particular Making Genetics employee's phone or email?
The Making Genetics annual revenue was $1 million in 2026.
2 people are employed at Making Genetics.
Making Genetics is based in Noain, Navarre.
The NAICS codes for Making Genetics are [54, 54171, 541713, 541, 5417].
The SIC codes for Making Genetics are [87, 873].